Videos

In this video, Dr Hudesman, from NYU Langone Health, highlights the current literature on the management of inflammatory bowel disease with underlying malignancy.

In this video, Walter Koltun, MD, from Penn State Health, discusses what gastroenterologists should be telling their patients about the expected outcomes of ileal pouch–anal anastomosis.

In this video, Jeffrey R. Curtis, MD, MPH, discusses the importance of vaccinations among individuals with immune-mediated inflammatory diseases, the potential for poor outcomes if patients do not follow a vaccination schedule, and more.

In this video, Dr Rubin, from the University of Chicago, discusses the challenges in the management of dysplasia and preventing cancer in patients with ulcerative colitis.

In this video, Dr Rubin, from the University of Chicago, discusses the importance of screening and surveillance for dysplasia and colorectal cancer among patients with inflammatory bowel disease, and more.

In this video, Vibeke Strand, MD, discusses immunogenicity and its contributing factors among individuals with immune-mediated inflammatory diseases.

While anti-tumor necrosis factor (TNF) inhibitors are effective treatments for patients with several inflammatory diseases, they may be associated with new onset psoriatic eruptions or paradoxical worsening of preexisting psoriatic skin disease. In an interview with The Dermatologist, Lourdes M. Perez-Chada, MD, MMSc, Sara Jiayang Li, BS, and Joseph F. Merola, MD, MMSc, discuss a novel treatment algorithm for managing patients treated with anti-TNF inhibitors who develop this adverse event.

Lindsey Albenberg, DO, from Children's Hospital of Philadelphia, discusses the role of the microbiome, as well as its influence on immunity and the development of pediatric inflammatory bowel disease.

In this video, Diane Mould, PhD, from Projections Research, discusses the important role of monoclonal antibodies in the management of inflammatory diseases.

In this video, James T. Rosenbaum, MD, from Oregon Health and Science University, discusses the current management of ocular inflammatory diseases, the importance of collaboration between a rheumatologist and ophthalmologist, and more.